Skip to main content
Top
Published in: Inflammation 4/2019

01-08-2019 | Septicemia | ORIGINAL ARTICLE

Sodium Butyrate Ameliorates Intestinal Injury and Improves Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis

Authors: Jiahong Fu, Guofu Li, Xingmao Wu, Bin Zang

Published in: Inflammation | Issue 4/2019

Login to get access

Abstract

Sepsis is a life-threatening condition with a high rate of mortality. Unfortunately, very few therapies can improve outcomes in patients with sepsis. Butyrate, which is the most potent histone deacetylase (HDAC) inhibitor among short-chain fatty acids, exerts anti-inflammatory effects in a variety of inflammatory diseases. Butyrate might thus be valuable in the treatment of sepsis, in which inhibition of overwhelming cytokine release is vitally important. Sepsis was induced in 7- to 8-week-old Sprague-Dawley rats by cecal ligation and puncture (CLP) with a 21-g double-puncture technique. Rats received an intravenous injection of normal saline (vehicle) or sodium butyrate (200 mg/kg) after CLP and were sacrificed 12 h later. Hematoxylin and eosin staining was performed to observe the intestinal mucosal morphology. RT-PCR and ELISA were used to determine the intestinal inflammatory response in vivo. Intestinal permeability was evaluated by measuring fluorescein isothiocyanate dextran (FD-4) absorption in vivo, and tight junction protein expression was examined by western blot. NF-κB p65 activities were assessed by western blot and immunohistochemistry. Sodium butyrate treatment improved the survival rate of CLP rats and alleviated sepsis-induced intestinal mucosal injury. Proinflammatory cytokine expression was lower in butyrate-treated rats than in the vehicle group. FD-4 leakage from the intestinal tract was reduced, and the expression levels of the tight junction proteins claudin-1 and ZO-1 were also restored in rats that received sodium butyrate treatment. These effects were associated with less NF-κB p65 nuclear translocation, whereas the expression of Iκ-Bα was not affected or even increased. Sodium butyrate mitigates the inflammatory response and maintains intestinal barrier function in polymicrobial sepsis partly through inhibition of NF-κB activation and may serve as a novel therapy for sepsis.
Literature
1.
go back to reference Dellinger, R.P., M.M. Levy, A. Rhodes, et al. 2013. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 39: 165–228.CrossRefPubMedPubMedCentral Dellinger, R.P., M.M. Levy, A. Rhodes, et al. 2013. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 39: 165–228.CrossRefPubMedPubMedCentral
2.
go back to reference Hotchkiss, R.S., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nature Reviews. Immunology 13: 862–874.CrossRefPubMedPubMedCentral Hotchkiss, R.S., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nature Reviews. Immunology 13: 862–874.CrossRefPubMedPubMedCentral
3.
go back to reference Assimakopoulos, S.F., C. Triantos, K. Thomopoulos, F. Fligou, I. Maroulis, M. Marangos, and C.A. Gogos. 2018. Gut-origin sepsis in the critically ill patient: Pathophysiology and treatment. Infection. 46: 751–760.CrossRefPubMed Assimakopoulos, S.F., C. Triantos, K. Thomopoulos, F. Fligou, I. Maroulis, M. Marangos, and C.A. Gogos. 2018. Gut-origin sepsis in the critically ill patient: Pathophysiology and treatment. Infection. 46: 751–760.CrossRefPubMed
4.
go back to reference Klingensmith, N.J., and C.M. Coopersmith. 2016. The gut as the motor of multiple organ dysfunction in critical illness. Critical Care Clinics 32: 203–212.CrossRefPubMedPubMedCentral Klingensmith, N.J., and C.M. Coopersmith. 2016. The gut as the motor of multiple organ dysfunction in critical illness. Critical Care Clinics 32: 203–212.CrossRefPubMedPubMedCentral
7.
go back to reference Vieira, E.L., A.J. Leonel, A.P. Sad, et al. 2012. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. The Journal of Nutritional Biochemistry 23: 430–436.CrossRefPubMed Vieira, E.L., A.J. Leonel, A.P. Sad, et al. 2012. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. The Journal of Nutritional Biochemistry 23: 430–436.CrossRefPubMed
8.
go back to reference Sun, J., F. Wang, H. Li, et al. 2015. Neuroprotective effect of sodium butyrate against cerebral ischemia/reperfusion injury in mice. BioMed Research International 2015: 395895.PubMedPubMedCentral Sun, J., F. Wang, H. Li, et al. 2015. Neuroprotective effect of sodium butyrate against cerebral ischemia/reperfusion injury in mice. BioMed Research International 2015: 395895.PubMedPubMedCentral
9.
go back to reference Qiao, Y.L., J.M. Qian, F.R. Wang, Z.Y. Ma, and Q.W. Wang. 2014. Butyrate protects liver against ischemia reperfusion injury by inhibiting nuclear factor kappa B activation in Kupffer cells. The Journal of Surgical Research 187: 653–659.CrossRefPubMed Qiao, Y.L., J.M. Qian, F.R. Wang, Z.Y. Ma, and Q.W. Wang. 2014. Butyrate protects liver against ischemia reperfusion injury by inhibiting nuclear factor kappa B activation in Kupffer cells. The Journal of Surgical Research 187: 653–659.CrossRefPubMed
10.
go back to reference Correa-Oliveira, R., J.L. Fachi, A. Vieira, et al. 2016. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunology. 5: e73.CrossRefPubMedPubMedCentral Correa-Oliveira, R., J.L. Fachi, A. Vieira, et al. 2016. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunology. 5: e73.CrossRefPubMedPubMedCentral
11.
go back to reference Liu, J., F. Wang, H. Luo, A. Liu, K. Li, C. Li, and Y. Jiang. 2016. Protective effect of butyrate against ethanol-induced gastric ulcers in mice by promoting the anti-inflammatory, anti-oxidant and mucosal defense mechanisms. International Immunopharmacology 30: 179–187.CrossRefPubMed Liu, J., F. Wang, H. Luo, A. Liu, K. Li, C. Li, and Y. Jiang. 2016. Protective effect of butyrate against ethanol-induced gastric ulcers in mice by promoting the anti-inflammatory, anti-oxidant and mucosal defense mechanisms. International Immunopharmacology 30: 179–187.CrossRefPubMed
12.
go back to reference Zhang, L.T., Y.M. Yao, J.Q. Lu, X.J. Yan, Y. Yu, and Z.Y. Sheng. 2007. Sodium butyrate prevents lethality of severe sepsis in rats. Shock. 27: 672–677.CrossRefPubMed Zhang, L.T., Y.M. Yao, J.Q. Lu, X.J. Yan, Y. Yu, and Z.Y. Sheng. 2007. Sodium butyrate prevents lethality of severe sepsis in rats. Shock. 27: 672–677.CrossRefPubMed
13.
go back to reference Zhang, L., S. Jin, C. Wang, R. Jiang, and J. Wan. 2010. Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. World Journal of Surgery 34: 1676–1683.CrossRefPubMed Zhang, L., S. Jin, C. Wang, R. Jiang, and J. Wan. 2010. Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. World Journal of Surgery 34: 1676–1683.CrossRefPubMed
14.
go back to reference Mishra, S.K., and S. Choudhury. 2018. Experimental protocol for cecal ligation and puncture model of polymicrobial sepsis and assessment of vascular functions in mice. Methods in Molecular Biology 1717: 161–187.CrossRefPubMed Mishra, S.K., and S. Choudhury. 2018. Experimental protocol for cecal ligation and puncture model of polymicrobial sepsis and assessment of vascular functions in mice. Methods in Molecular Biology 1717: 161–187.CrossRefPubMed
15.
go back to reference Chiu, C.J., A.H. McArdle, R. Brown, et al. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Archives of Surgery 101: 478–483.CrossRefPubMed Chiu, C.J., A.H. McArdle, R. Brown, et al. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Archives of Surgery 101: 478–483.CrossRefPubMed
16.
go back to reference Kao, N.R., A. Xenocostas, D.K. Driman, et al. 2011. Recombinant human erythropoietin improves gut barrier function in a hemorrhagic shock and resuscitation rat model. The Journal of Trauma 71: S456–S461.CrossRefPubMed Kao, N.R., A. Xenocostas, D.K. Driman, et al. 2011. Recombinant human erythropoietin improves gut barrier function in a hemorrhagic shock and resuscitation rat model. The Journal of Trauma 71: S456–S461.CrossRefPubMed
17.
go back to reference Meng, M., N.J. Klingensmith, and C.M. Coopersmith. 2017. New insights into the gut as the driver of critical illness and organ failure. Current Opinion in Critical Care 23: 143–148.CrossRefPubMedPubMedCentral Meng, M., N.J. Klingensmith, and C.M. Coopersmith. 2017. New insights into the gut as the driver of critical illness and organ failure. Current Opinion in Critical Care 23: 143–148.CrossRefPubMedPubMedCentral
18.
go back to reference Ni, Y.F., J. Wang, X.L. Yan, et al. 2010. Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice. Respiratory Research 11. Ni, Y.F., J. Wang, X.L. Yan, et al. 2010. Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice. Respiratory Research 11.
19.
go back to reference Wang, F., Z. Jin, K. Shen, T. Weng, Z. Chen, J. Feng, Z. Zhang, J. Liu, X. Zhang, and M. Chu. 2017. Butyrate pretreatment attenuates heart depression in a mice model of endotoxin-induced sepsis via anti-inflammation and anti-oxidation. The American Journal of Emergency Medicine 35: 402–409.CrossRefPubMed Wang, F., Z. Jin, K. Shen, T. Weng, Z. Chen, J. Feng, Z. Zhang, J. Liu, X. Zhang, and M. Chu. 2017. Butyrate pretreatment attenuates heart depression in a mice model of endotoxin-induced sepsis via anti-inflammation and anti-oxidation. The American Journal of Emergency Medicine 35: 402–409.CrossRefPubMed
20.
go back to reference Dejager, L., I. Pinheiro, E. Dejonckheere, and C. Libert. 2011. Cecal ligation and puncture: The gold standard model for polymicrobial sepsis? Trends in Microbiology 19: 198–208.CrossRefPubMed Dejager, L., I. Pinheiro, E. Dejonckheere, and C. Libert. 2011. Cecal ligation and puncture: The gold standard model for polymicrobial sepsis? Trends in Microbiology 19: 198–208.CrossRefPubMed
21.
go back to reference Gentile, L.F., A.G. Cuenca, E.L. Vanzant, P.A. Efron, B. McKinley, F. Moore, and L.L. Moldawer. 2013. Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? Methods. 61: 3–9.CrossRefPubMedPubMedCentral Gentile, L.F., A.G. Cuenca, E.L. Vanzant, P.A. Efron, B. McKinley, F. Moore, and L.L. Moldawer. 2013. Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? Methods. 61: 3–9.CrossRefPubMedPubMedCentral
22.
go back to reference Aksoy, A.N., A. Toker, M. Celik, et al. 2014. The effect of progesterone on systemic inflammation and oxidative stress in the rat model of sepsis. Indian Journal of Pharmacology 46: 622–626.CrossRefPubMedPubMedCentral Aksoy, A.N., A. Toker, M. Celik, et al. 2014. The effect of progesterone on systemic inflammation and oxidative stress in the rat model of sepsis. Indian Journal of Pharmacology 46: 622–626.CrossRefPubMedPubMedCentral
23.
go back to reference Huang, B., X.D. Yang, A. Lamb, and L.F. Chen. 2010. Posttranslational modifications of NF-kappaB: Another layer of regulation for NF-kappaB signaling pathway. Cellular Signalling 22: 1282–1290.CrossRefPubMedPubMedCentral Huang, B., X.D. Yang, A. Lamb, and L.F. Chen. 2010. Posttranslational modifications of NF-kappaB: Another layer of regulation for NF-kappaB signaling pathway. Cellular Signalling 22: 1282–1290.CrossRefPubMedPubMedCentral
24.
go back to reference Liu, S.F., and A.B. Malik. 2006. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 290: L622–L645.CrossRefPubMed Liu, S.F., and A.B. Malik. 2006. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology 290: L622–L645.CrossRefPubMed
25.
go back to reference Li, Q., Q. Zhang, C. Wang, X. Liu, N. Li, and J. Li. 2009. Disruption of tight junctions during polymicrobial sepsis in vivo. The Journal of Pathology 218: 210–221.CrossRefPubMed Li, Q., Q. Zhang, C. Wang, X. Liu, N. Li, and J. Li. 2009. Disruption of tight junctions during polymicrobial sepsis in vivo. The Journal of Pathology 218: 210–221.CrossRefPubMed
26.
go back to reference Lechuga, S., and A.I. Ivanov. 2017. Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms. Biochimica et Biophysica Acta, Molecular Cell Research 1864: 1183–1194.CrossRefPubMed Lechuga, S., and A.I. Ivanov. 2017. Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms. Biochimica et Biophysica Acta, Molecular Cell Research 1864: 1183–1194.CrossRefPubMed
27.
go back to reference Berkes, J., V.K. Viswanathan, S.D. Savkovic, and G. Hecht. 2003. Intestinal epithelial responses to enteric pathogens: Effects on the tight junction barrier, ion transport, and inflammation. Gut. 52: 439–451.CrossRefPubMedPubMedCentral Berkes, J., V.K. Viswanathan, S.D. Savkovic, and G. Hecht. 2003. Intestinal epithelial responses to enteric pathogens: Effects on the tight junction barrier, ion transport, and inflammation. Gut. 52: 439–451.CrossRefPubMedPubMedCentral
28.
go back to reference Singh, N., M. Thangaraju, P.D. Prasad, P.M. Martin, N.A. Lambert, T. Boettger, S. Offermanns, and V. Ganapathy. 2010. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. The Journal of Biological Chemistry 285: 27601–27608.CrossRefPubMedPubMedCentral Singh, N., M. Thangaraju, P.D. Prasad, P.M. Martin, N.A. Lambert, T. Boettger, S. Offermanns, and V. Ganapathy. 2010. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. The Journal of Biological Chemistry 285: 27601–27608.CrossRefPubMedPubMedCentral
29.
go back to reference Park, J., M. Kim, S.G. Kang, A.H. Jannasch, B. Cooper, J. Patterson, and C.H. Kim. 2015. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunology 8: 80–93.CrossRefPubMed Park, J., M. Kim, S.G. Kang, A.H. Jannasch, B. Cooper, J. Patterson, and C.H. Kim. 2015. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunology 8: 80–93.CrossRefPubMed
30.
go back to reference Ito, K. 2007. Impact of post-translational modifications of proteins on the inflammatory process. Biochemical Society Transactions 35: 281–283.CrossRefPubMed Ito, K. 2007. Impact of post-translational modifications of proteins on the inflammatory process. Biochemical Society Transactions 35: 281–283.CrossRefPubMed
31.
go back to reference Flint, H.J., K.P. Scott, P. Louis, and S.H. Duncan. 2012. The role of the gut microbiota in nutrition and health. Nature Reviews. Gastroenterology & Hepatology 9: 577–589.CrossRef Flint, H.J., K.P. Scott, P. Louis, and S.H. Duncan. 2012. The role of the gut microbiota in nutrition and health. Nature Reviews. Gastroenterology & Hepatology 9: 577–589.CrossRef
32.
go back to reference Kiernan, R., V. Bres, R.W. Ng, et al. 2003. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. The Journal of Biological Chemistry 278: 2758–2766.CrossRefPubMed Kiernan, R., V. Bres, R.W. Ng, et al. 2003. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. The Journal of Biological Chemistry 278: 2758–2766.CrossRefPubMed
33.
go back to reference Ziesche, E., D. Kettner-Buhrow, A. Weber, et al. 2013. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-kappaB. Nucleic Acids Research 41: 90–109.CrossRefPubMed Ziesche, E., D. Kettner-Buhrow, A. Weber, et al. 2013. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-kappaB. Nucleic Acids Research 41: 90–109.CrossRefPubMed
34.
go back to reference Leus, N.G., M.R. Zwinderman, and F.J. Dekker. 2016. Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-kappaB-mediated inflammation. Current Opinion in Chemical Biology 33: 160–168.CrossRefPubMedPubMedCentral Leus, N.G., M.R. Zwinderman, and F.J. Dekker. 2016. Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-kappaB-mediated inflammation. Current Opinion in Chemical Biology 33: 160–168.CrossRefPubMedPubMedCentral
35.
go back to reference Li, H., W. Han, V. Polosukhin, et al. 2013. NF-kappaB inhibition after cecal ligation and puncture reduces sepsis-associated lung injury without altering bacterial host defense. Mediators of Inflammation 503213: 2013. Li, H., W. Han, V. Polosukhin, et al. 2013. NF-kappaB inhibition after cecal ligation and puncture reduces sepsis-associated lung injury without altering bacterial host defense. Mediators of Inflammation 503213: 2013.
36.
go back to reference Chen, L.F., and W.C. Greene. 2004. Shaping the nuclear action of NF-kappaB. Nature Reviews. Molecular Cell Biology 5: 392–401.CrossRefPubMed Chen, L.F., and W.C. Greene. 2004. Shaping the nuclear action of NF-kappaB. Nature Reviews. Molecular Cell Biology 5: 392–401.CrossRefPubMed
37.
go back to reference Kaplan, J., M. Nowell, R. Chima, and B. Zingarelli. 2014. Pioglitazone reduces inflammation through inhibition of NF-kappaB in polymicrobial sepsis. Innate Immunity 20: 519–528.CrossRefPubMed Kaplan, J., M. Nowell, R. Chima, and B. Zingarelli. 2014. Pioglitazone reduces inflammation through inhibition of NF-kappaB in polymicrobial sepsis. Innate Immunity 20: 519–528.CrossRefPubMed
38.
go back to reference Ghizzoni, M., H.J. Haisma, H. Maarsingh, and F.J. Dekker. 2011. Histone acetyltransferases are crucial regulators in NF-kappaB mediated inflammation. Drug Discovery Today 16: 504–511.CrossRefPubMed Ghizzoni, M., H.J. Haisma, H. Maarsingh, and F.J. Dekker. 2011. Histone acetyltransferases are crucial regulators in NF-kappaB mediated inflammation. Drug Discovery Today 16: 504–511.CrossRefPubMed
39.
go back to reference Spange, S., T. Wagner, T. Heinzel, and O.H. Krämer. 2009. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. The International Journal of Biochemistry & Cell Biology 41: 185–198.CrossRef Spange, S., T. Wagner, T. Heinzel, and O.H. Krämer. 2009. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. The International Journal of Biochemistry & Cell Biology 41: 185–198.CrossRef
40.
go back to reference Choo, Q.Y., P.C. Ho, and H.S. Lin. 2008. Histone deacetylase inhibitors: New hope for rheumatoid arthritis? Current Pharmaceutical Design 14: 803–820.CrossRefPubMed Choo, Q.Y., P.C. Ho, and H.S. Lin. 2008. Histone deacetylase inhibitors: New hope for rheumatoid arthritis? Current Pharmaceutical Design 14: 803–820.CrossRefPubMed
41.
go back to reference Egorin, M.J., Z.M. Yuan, D.L. Sentz, K. Plaisance, and J.L. Eiseman. 1999. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemotherapy and Pharmacology 43: 445–453.CrossRefPubMed Egorin, M.J., Z.M. Yuan, D.L. Sentz, K. Plaisance, and J.L. Eiseman. 1999. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemotherapy and Pharmacology 43: 445–453.CrossRefPubMed
42.
go back to reference Qiao, Y., J. Qian, Q. Lu, Y. Tian, Q. Chen, and Y. Zhang. 2015. Protective effects of butyrate on intestinal ischemia-reperfusion injury in rats. The Journal of Surgical Research 197: 324–330.CrossRefPubMed Qiao, Y., J. Qian, Q. Lu, Y. Tian, Q. Chen, and Y. Zhang. 2015. Protective effects of butyrate on intestinal ischemia-reperfusion injury in rats. The Journal of Surgical Research 197: 324–330.CrossRefPubMed
Metadata
Title
Sodium Butyrate Ameliorates Intestinal Injury and Improves Survival in a Rat Model of Cecal Ligation and Puncture-Induced Sepsis
Authors
Jiahong Fu
Guofu Li
Xingmao Wu
Bin Zang
Publication date
01-08-2019
Publisher
Springer US
Published in
Inflammation / Issue 4/2019
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-019-00987-2

Other articles of this Issue 4/2019

Inflammation 4/2019 Go to the issue